4.42 USD
↗ 0.20 (4.72%)PRE MARKET (AS OF 09:17 AM EDT)
Shares of ENDRA Life Sciences Inc. Common Stock (NDRA) are trading at $4.42. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest NDRA is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 4, 2026.